Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSEPH M NEWMARK

Allopathic & Osteopathic Physicians Dermatology

NPI
1902939317
CMS profile
268108
Location
VESTAL, NY

General Payments · PY2018–2024

$10,138.02

  • Reported across 447 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$720.04

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $720.04 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $156.43 10
Lilly USA, LLC $137.45 8
SUN PHARMACEUTICAL INDUSTRIES INC. $84.91 4
ORGANOGENESIS INC. $72.75 2
NOVARTIS PHARMACEUTICALS CORPORATION $63.64 3
Incyte Corporation $55.20 2
GENZYME CORPORATION $51.14 2
LEO Pharma Inc. $24.79 1
PFIZER INC. $21.15 1
UCB, Inc. $19.47 1
Amgen Inc. $18.63 1
Galderma Laboratories, L.P. $14.48 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,031.34 90
PY2019 $2,452.93 107
PY2020 $1,158.71 47
PY2021 $1,186.39 61
PY2022 $1,273.37 51
PY2023 $1,315.24 55
PY2024 $720.04 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $8.31 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105114392 CMS
ABBVIE INC. $3.48 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105114394 CMS
ABBVIE INC. $5.20 03/13/2024 Food and Beverage Undisputed 01/23/2026 1105114396 CMS
ABBVIE INC. $6.83 03/13/2024 Food and Beverage Undisputed 01/23/2026 1105114398 CMS
ABBVIE INC. $27.32 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105114400 CMS
ABBVIE INC. $27.15 08/15/2024 Food and Beverage Undisputed 01/23/2026 1105114402 CMS
ABBVIE INC. $33.58 10/22/2024 Food and Beverage Undisputed 01/23/2026 1105114404 CMS
ABBVIE INC. $20.08 12/04/2024 Food and Beverage Undisputed 01/23/2026 1105114406 CMS
ABBVIE INC. $5.27 12/05/2024 Food and Beverage Undisputed 01/23/2026 1105114408 CMS
ABBVIE INC. $19.21 12/09/2024 Food and Beverage Undisputed 01/23/2026 1105114410 CMS
Amgen Inc. $18.63 09/23/2024 Food and Beverage Undisputed 01/23/2026 1117338617 CMS
Galderma Laboratories, L.P. $14.48 06/12/2024 Food and Beverage Undisputed 01/23/2026 1145318582 CMS
GENZYME CORPORATION $27.40 02/07/2024 Food and Beverage Undisputed 01/23/2026 1139616188 CMS
GENZYME CORPORATION $23.74 09/04/2024 Food and Beverage Undisputed 01/23/2026 1139616270 CMS
Incyte Corporation $28.08 07/31/2024 Food and Beverage Undisputed 01/23/2026 1141218114 CMS
Incyte Corporation $27.12 09/19/2024 Food and Beverage Undisputed 01/23/2026 1141244604 CMS
LEO Pharma Inc. $24.79 05/14/2024 Food and Beverage Undisputed 01/23/2026 1152644139 CMS
Lilly USA, LLC $14.87 01/23/2024 Food and Beverage Undisputed 01/23/2026 1135074525 CMS
Lilly USA, LLC $7.87 02/21/2024 Food and Beverage Undisputed 01/23/2026 1135074527 CMS
Lilly USA, LLC $18.02 04/09/2024 Food and Beverage Undisputed 01/23/2026 1135082032 CMS
Lilly USA, LLC $23.76 06/06/2024 Food and Beverage Undisputed 01/23/2026 1135106635 CMS
Lilly USA, LLC $24.34 06/10/2024 Food and Beverage Undisputed 01/23/2026 1135084716 CMS
Lilly USA, LLC $13.56 06/11/2024 Food and Beverage Undisputed 01/23/2026 1135105677 CMS
Lilly USA, LLC $15.26 08/07/2024 Food and Beverage Undisputed 01/23/2026 1135084714 CMS
Lilly USA, LLC $19.77 11/06/2024 Food and Beverage Undisputed 01/23/2026 1135086579 CMS
Novartis Pharmaceuticals Corporation $27.28 01/30/2024 Food and Beverage Undisputed 01/23/2026 1087032162 CMS
Novartis Pharmaceuticals Corporation $13.79 02/13/2024 Food and Beverage Undisputed 01/23/2026 1087032164 CMS
Novartis Pharmaceuticals Corporation $22.57 08/06/2024 Food and Beverage Undisputed 01/23/2026 1087032168 CMS
Organogenesis Inc. $38.79 02/14/2024 Food and Beverage Undisputed 01/23/2026 1145440861 CMS
Organogenesis Inc. $33.96 08/21/2024 Food and Beverage Undisputed 01/23/2026 1145440863 CMS
PFIZER INC. $21.15 03/07/2024 Food and Beverage Undisputed 01/23/2026 1131278981 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $19.31 04/03/2024 Food and Beverage Undisputed 01/23/2026 1152164226 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $19.71 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152164228 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $23.23 09/27/2024 Food and Beverage Undisputed 01/23/2026 1152164230 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $22.66 12/09/2024 Food and Beverage Undisputed 01/23/2026 1152164224 CMS
UCB, Inc. $19.47 11/13/2024 Food and Beverage Undisputed 01/23/2026 1143402274 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.